Academic literature on the topic 'Hepatorenalt syndrom'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Hepatorenalt syndrom.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Hepatorenalt syndrom"

1

Demırtaş, Selda, Murat Can, and Ayşegül Yarpuzlu. "Hepatorenal syndrome / Hepatorenales Syndrom." LaboratoriumsMedizin 30, no. 5 (2006): 272–79. http://dx.doi.org/10.1515/jlm.2006.998.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Gerbes and Gülberg. "Extrahepatische Manifestationen bei Lebererkrankungen: Niere." Praxis 95, no. 40 (2006): 1535–38. http://dx.doi.org/10.1024/1661-8157.95.40.1535.

Full text
Abstract:
Bei Lebererkrankungen ist ein Nierenversagen meist funktioneller Natur. Es handelt sich um eine prärenale Niereninsuffizienz oder ein hepatorenales Syndrom (HRS). Dies muss von organischen Nierenschäden (meist akut-tubuläre Nekrose, ATN) unterschieden werden. Um ein funktionelles Nierenversagen zu vermeiden, ist eine vorsichtige Diuretikatherapie wie auch eine intravenöse Albuminsubstitution nach Parazentese wichtig. Zur Prophylaxe des hepatorenalen Syndroms soll eine spontan bakterielle Peritonitis zusätzlich zu Antibiotika auch mit Albumininfusion behandelt werden. Patienten mit hepatorenale
APA, Harvard, Vancouver, ISO, and other styles
3

Krátká, Karolína, Pavla Libicherová, Nikola Mejzlíková, and Ivan Rychlík. "Hepatorenal syndrome - update 2020." Vnitřní lékařství 66, no. 3 (2020): e58-e62. http://dx.doi.org/10.36290/vnl.2020.062.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ackermann, Daniel. "Therapie von Aszites, Hyponatriämie und hepatorenalem Syndrom bei der Leberzirrhose." Therapeutische Umschau 66, no. 11 (2009): 747–51. http://dx.doi.org/10.1024/0040-5930.66.11.747.

Full text
Abstract:
Aszites und Hyponatriämie sind häufige Komplikationen der fortgeschrittenen Leberzirrhose. Aszites entsteht durch eine pathologisch erhöhte Natriumretention in den Nieren, welche zu einer Expansion des Extrazellulärvolumens und zur Flüssigkeitsansammlung im Peritonealraum führt. Durch die verminderte Fähigkeit der Nieren, freies Wasser zu eliminieren, kommt es zu einer hypervolämen Hyponatriämie. Die genaue Pathogenese der Natriumretention ist unklar, währenddem die Hyponatriämie durch eine Hypersekretion des antidiuretischen Hormons (Vasopressin) aus der Neurohypophyse zustande kommt. Es gibt
APA, Harvard, Vancouver, ISO, and other styles
5

Suneja, Manish, Fan Tang, Joseph E. Cavanaugh, Linnea A. Polgreen, and Philip M. Polgreen. "Population Based Trends in the Incidence of Hospital Admission for the Diagnosis of Hepatorenal Syndrome: 1998–2011." International Journal of Nephrology 2016 (2016): 1–6. http://dx.doi.org/10.1155/2016/8419719.

Full text
Abstract:
Background and Objectives. Hepatorenal syndrome carries a high risk of mortality. Understanding the incidence and mortality trends in hepatorenal syndrome will help inform future studies regarding the safety and efficacy of potential therapeutic interventions.Design and Methods. We conducted a retrospective cohort study using the Nationwide Inpatient Sample. We identified hospitalizations from January 1998–June 2011 with a primary diagnosis of hepatorenal syndrome. To characterize the incidence trends in monthly hepatorenal syndrome hospitalizations, we fit a piecewise linear model with a chan
APA, Harvard, Vancouver, ISO, and other styles
6

Francoz, Claire, François Durand, Jeffrey A. Kahn, Yuri S. Genyk, and Mitra K. Nadim. "Hepatorenal Syndrome." Clinical Journal of the American Society of Nephrology 14, no. 5 (2019): 774–81. http://dx.doi.org/10.2215/cjn.12451018.

Full text
Abstract:
Hepatorenal syndrome is a severe complication of end-stage cirrhosis characterized by increased splanchnic blood flow, hyperdynamic state, a state of decreased central volume, activation of vasoconstrictor systems, and extreme kidney vasoconstriction leading to decreased GFR. The contribution of systemic inflammation, a key feature of cirrhosis, in the development of hepatorenal syndrome has been highlighted in recent years. The mechanisms by which systemic inflammation precipitates kidney circulatory changes during hepatorenal syndrome need to be clarified. Early diagnosis is central in the m
APA, Harvard, Vancouver, ISO, and other styles
7

Kurschat, Christine, Franziska Grundmann, and Thomas Benzing. "Das hepatorenale Syndrom." Intensivmedizin up2date 6, no. 01 (2010): 41–52. http://dx.doi.org/10.1055/s-0029-1243820.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Heemann, Uwe, Hermann Füeßl, and Lutz Renders. "Das hepatorenale Syndrom." DMW - Deutsche Medizinische Wochenschrift 140, no. 20 (2015): 1520–23. http://dx.doi.org/10.1055/s-0041-105807.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hasper, Dietrich, and Achim Jörres. "Das hepatorenale Syndrom." Dialyse aktuell 20, no. 05 (2016): 228–32. http://dx.doi.org/10.1055/s-0042-108125.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Matevossian, Edouard. "Das hepatorenale Syndrom." Dialyse aktuell 17, no. 02 (2013): 78. http://dx.doi.org/10.1055/s-0033-1343389.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Hepatorenalt syndrom"

1

Svantesson, Elise. "Hepatorenalt syndrom : Rådande teorier om patomekanismer och terlipressins plats i behandlingen." Thesis, Umeå universitet, Farmakologi, 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-136456.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Anand, Radhika Saraswattie. "A model of hepatorenal syndrome." Thesis, University College London (University of London), 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.405754.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Huber, Elisabeth. "Pharmakotherapie des hepatorenalen Syndroms." Diss., lmu, 2009. http://nbn-resolving.de/urn:nbn:de:bvb:19-108990.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Koch, Nikolaus Heinrich [Verfasser], Wolfgang L. E. [Akademischer Betreuer] Huber, Wolfgang L. E. [Gutachter] Huber, and Roland M. [Gutachter] Schmid. "Eine randomisierte kontrollierte Studie zur zielgerichteten Therapie des hepatorenalen Syndroms (Early goal-directed volume resuscitation in hepatorenal syndrome (RACEHORSE)) / Nikolaus Heinrich Koch ; Gutachter: Wolfgang L. E. Huber, Roland M. Schmid ; Betreuer: Wolfgang L. E. Huber." München : Universitätsbibliothek der TU München, 2020. http://d-nb.info/121529333X/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Snowdon, Victoria Katherine. "Relaxin as a therapeutic haemodynamic modulator in liver disease." Thesis, University of Edinburgh, 2016. http://hdl.handle.net/1842/23508.

Full text
Abstract:
Introduction: Hepatorenal syndrome (HRS) is a common complication of advanced cirrhosis with a high mortality rate and limited treatment options. Central to its pathogenesis is severe, but potentially reversible, renal vasoconstriction leading to functional renal failure. Current pharmacological treatment using splanchnic vasoconstrictors is suboptimal and prognosis without liver transplantation is dismal. The peptide hormone relaxin (RLN) mediates haemodynamic adaptations to pregnancy including increased renal blood flow (RBF) and glomerular filtration rate (GFR). I hypothesised that exogenou
APA, Harvard, Vancouver, ISO, and other styles
6

Glowa, Fabian [Verfasser], and Ulrike [Akademischer Betreuer] Denzer. "Terlipressin in der Behandlung des hepatorenalen Syndroms : Eine klinische Evaluation / Fabian Glowa. Betreuer: Ulrike Denzer." Hamburg : Staats- und Universitätsbibliothek Hamburg, 2011. http://d-nb.info/1020458135/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Austgen, Thomas [Verfasser]. "Die klinische Bedeutung von Biomarkern des Zelltodes und der Inflammation bei Patienten mit Leberzirrhose und hepatorenalem Syndrom / Thomas Austgen." Mainz : Universitätsbibliothek der Johannes Gutenberg-Universität Mainz, 2021. http://d-nb.info/1237814626/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Tonsen, Marie-Thérèse [Verfasser]. "Behandlung des hepatorenalen Syndroms mit Terlipressin und Humanalbumin bei Patienten mit Leberzirrhose und Auswirkungen auf die Lebertransplantation / Marie-Thérèse Tonsen." Mainz : Universitätsbibliothek der Johannes Gutenberg-Universität Mainz, 2020. http://d-nb.info/1224810732/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kühnel, Markus. "Diagnostische Wertigkeit der fraktionellen Harnstoffexkretion, des Serum Cystatin C, sowie der glomerulären Filtrationsrate nach MDRD zur Detektion eines hepatorenalen Syndroms bei Leberzirrhose." kostenfrei, 2008. http://www.opus-bayern.de/uni-regensburg/volltexte/2009/1127/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Martín, Llahí Marta. "Estudis sobre la insuficiència renal en la cirrosi hepàtica: Anàlisi del pronòstic i investigació en el tractament farmacològic de la síndrome hepatorenal." Doctoral thesis, Universitat de Barcelona, 2013. http://hdl.handle.net/10803/116494.

Full text
Abstract:
Des que es va definir la síndrome hepatorenal (SHR), als anys 60 del segle passat, s’han fet grans progressos en el coneixement d’aquesta entitat. La SHR és una insuficiència renal característica dels pacients amb cirrosi hepàtica (CH) amb molt mal pronòstic a curt plaç. El tractament curatiu és el trasplantament hepàtic perquè elimina la CH que és l’origen del problema. Però no sempre està indicat el trasplantament o no s’arriba a temps de realitzar-lo. Els estudis basats en la fisiopatologia de la SHR han estat la base per investigar sobre tractaments que puguin revertir la insuficiència ren
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Hepatorenalt syndrom"

1

Ascites, hyponatremia, and hepatorenal syndrome: Progress in treatment. Karger, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Gerbes, A. L. Ascites, hyponatremia, and hepatorenal syndrome: Progress in treatment. Karger, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Cárdenas, Andrés, and Pere Ginès. The patient with hepatorenal syndrome. Edited by Giuseppe Remuzzi. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199592548.003.0169_update_001.

Full text
Abstract:
Hepatorenal syndrome (HRS) is a dreaded and common complication of patients with end-stage liver disease. The syndrome is characterized by functional renal failure due to renal vasoconstriction in the absence of underlying kidney pathology. The pathogenesis of HRS is the result of an extreme underfilling of the arterial circulation secondary to an arterial vasodilation located in the splanchnic circulation. This phenomenon triggers a compensatory response with activation of vasoconstrictor systems leading to intense renal vasoconstriction.Besides HRS, there are several other causes of renal fa
APA, Harvard, Vancouver, ISO, and other styles
4

MA, Carla Davis. Hepatorenal Syndrome: Causes, Tests and Treatment Options. CreateSpace Independent Publishing Platform, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Gerbes, A. L., ed. Ascites, Hyponatremia and Hepatorenal Syndrome: Progress in Treatment. S. Karger AG, 2010. http://dx.doi.org/10.1159/isbn.978-3-8055-9592-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Shanmugam, Naresh P., and Dharam Basude. Complications of chronic liver disease. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198759928.003.0067.

Full text
Abstract:
The chapter on complications of chronic liver disease gives an overview of the definition, pathophysiology, diagnosis, and management of the various complications that accompany chronic liver disease. It includes among others, malnutrition and growth failure, hepatic encephalopathy, hepatopulmonary syndrome, hepatorenal syndrome, portal hypertension, and spontaneous bacterial peritonitis.
APA, Harvard, Vancouver, ISO, and other styles
7

The kidney in liver disease. 4th ed. Hanley & Belfus, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

1937-, Epstein Murray, ed. The Kidney in liver disease. 3rd ed. Williams & Wilkins, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Williams, Ashleigh, and John Christie. Hepatic disease. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198719410.003.0007.

Full text
Abstract:
This chapter describes the anaesthetic management of the patient with liver disease and its sequelae. Acute liver failure and chronic liver failure are discussed, together with their anaesthetic implications on coagulation and drug metabolism. Major sequelae of liver disease are discussed, including portal hypertension, varices, and hepatorenal syndrome. The preoperative investigation and optimization, treatment, and anaesthetic management of the patient with liver failure are described. The investigation and management of post-operative liver dysfunction are described. The anaesthetic managem
APA, Harvard, Vancouver, ISO, and other styles
10

Wiffen, Philip, Marc Mitchell, Melanie Snelling, and Nicola Stoner. Patient management issues. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198735823.003.0010.

Full text
Abstract:
This chapter outlines information relevant to pharmacists and other healthcare professionals on patient management issues related to special populations. It covers management of patients with liver impairment, including drug use, drug dosing, and hepatorenal syndrome. Drug use and dosing in renal impairment is discussed and the various methods of assessing or calculating glomerular filtration rate are reviewed. The use of drugs in pregnancy and breastfeeding is discussed with guidance given on assessing the risks versus benefits of drug use in these situations. Drugs and dietary considerations
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Hepatorenalt syndrom"

1

Huschak, G., U. X. Kaisers, and S. Laudi. "Hepatorenales Syndrom." In Weiterbildung Anästhesiologie. Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-662-46515-8_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Angeli, Paolo, Filippo Morando, Marta Cavallin, and Salvatore Piano. "Hepatorenal Syndrome." In Contributions to Nephrology. KARGER, 2011. http://dx.doi.org/10.1159/000329235.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

O’Riordan, Aisling. "Hepatorenal Syndrome." In Practical Nephrology. Springer London, 2014. http://dx.doi.org/10.1007/978-1-4471-5547-8_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Angeli, P. "Hepatorenal Syndrome." In Yearbook of Intensive Care and Emergency Medicine. Springer Berlin Heidelberg, 2006. http://dx.doi.org/10.1007/3-540-33396-7_61.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kuntz, Erwin, and Hans-Dieter Kuntz. "Hepatorenal syndrome." In Hepatology. Springer Berlin Heidelberg, 2002. http://dx.doi.org/10.1007/978-3-662-04680-7_17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Metze, Dieter, Vanessa F. Cury, Ricardo S. Gomez, et al. "Hepatorenal Syndrome." In Encyclopedia of Molecular Mechanisms of Disease. Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-29676-8_781.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ando, Yumi, and Joseph Ahn. "Hepatorenal Syndrome." In Liver Disease. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-98506-0_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hasper, Dietrich, and Thomas Berg. "Hepatorenal Syndrome." In Management of Acute Kidney Problems. Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-69441-0_31.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Mandal, Anil K. "Hepatorenal Syndrome." In Assessment of Urinary Sediment by Electron Microscopy. Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-1851-4_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Dancygier, Henryk. "Hepatorenal Syndrome." In Mount Sinai Expert Guides: Hepatology. John Wiley & Sons, Ltd, 2014. http://dx.doi.org/10.1002/9781118748626.ch22.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Hepatorenalt syndrom"

1

Yun, Jeong H., and Glenn Eiger. "Hepatorenal Syndrome: Clinical Features And Outcome." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a5829.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Lagunov, Alexey, Darina Lagunova, and Irina Berdennikova. "The program of hepatorenal syndrome at the persons abusing alcohol screening carrying out." In 2013 IEEE 7th International Conference on Intelligent Data Acquisition and Advanced Computing Systems: Technology and Applications (IDAACS). IEEE, 2013. http://dx.doi.org/10.1109/idaacs.2013.6662688.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Nguyen-Tat, M., MT Häring, T. Zimmermann, et al. "Effekt einer Terlipressin-Behandlung bei Patienten auf der LTX-Warteliste mit Leberzirrhose und hepatorenalem Syndrom (HRS)." In Viszeralmedizin 2017. Georg Thieme Verlag KG, 2017. http://dx.doi.org/10.1055/s-0037-1605050.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Grotemeyer, K., F. Lammert, A. Arslanow, and R. Kaiser. "Die Bedeutung der Transienten Elastografie (Fibroscan) in Bezug auf die Entwicklung des hepatorenalen Syndroms (HRS)." In Viszeralmedizin 2017. Georg Thieme Verlag KG, 2017. http://dx.doi.org/10.1055/s-0037-1605078.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Agrawal, Jatin, Ashish Kumar, Anil Arora, et al. "IDDF2020-ABS-0206 Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and hepatorenal syndrome – acute kidney injury (HRS-AKI) according to new International club of ascites (ICA) criteria." In Abstracts of the International Digestive Disease Forum (IDDF), 22–23 November 2020, Hong Kong. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2020. http://dx.doi.org/10.1136/gutjnl-2020-iddf.16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!